Latest Tax Incentives News

Page 29 of 36
Argenica Therapeutics reported a 16% reduction in half-year losses to $1.19 million, buoyed by a 29% increase in other income largely from R&D tax incentives, as it advances its neuroprotective drug development.
Ada Torres
Ada Torres
11 Feb 2025
Spacetalk Ltd has secured a $428,853 R&D tax rebate from the Australian Taxation Office, reinforcing its commitment to innovation while reporting a 16% increase in Annual Recurring Revenue and significant cost reductions.
Sophie Babbage
Sophie Babbage
7 Feb 2025
AdAlta Limited is accelerating its 'East to West' cellular immunotherapy strategy, aiming to bridge Asian innovation with Western clinical development and manufacturing to target solid cancers. The company plans to secure three assets by the end of 2025 and initiate clinical trials, positioning itself as a leader in this emerging market.
Ada Torres
Ada Torres
7 Feb 2025
Infini Resources has successfully raised AUD$3.4 million through a flow-through share placement at a significant premium, positioning the company to aggressively advance exploration at its Portland Creek Uranium Project in Newfoundland.
Victor Sage
Victor Sage
6 Feb 2025
Entyr Limited has received a $3.79 million R&D tax incentive payment for its innovative thermal desorption project targeting rubber waste, reinforcing its position in sustainable tyre recycling technology.
Victor Sage
Victor Sage
3 Feb 2025
Redstone Resources is gearing up for a pivotal drilling campaign at its 100%-owned West Musgrave Copper Project in Western Australia, backed by a $220,000 government grant and strong historical copper grades.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Micro-X announces a strategic pivot towards medical imaging, anchored by a $25 million US government contract to develop a portable Full Body CT scanner, while discontinuing its Argus security operations to streamline costs.
Victor Sage
Victor Sage
31 Jan 2025
AdNeo reported a standout quarter with record new sales led by its US-based Art of Mentoring division and significant operational cost reductions, positioning the company for growth through strategic acquisitions.
Sophie Babbage
Sophie Babbage
31 Jan 2025
Recce Pharmaceuticals has gained key regulatory and ethics approvals for its Phase 3 clinical trial in Indonesia and completed patient dosing for its Phase II trial, while securing a substantial A$6.75 million R&D tax rebate to bolster its financial position.
Victor Sage
Victor Sage
31 Jan 2025
Cardiex Limited reported a $2.94 million cash outflow for Q2 FY2025 but bolstered its balance sheet with a $3.25 million placement. The company has begun delivering its CONNEQT Pulse units, signaling a new revenue stream and ongoing R&D investment.
Ada Torres
Ada Torres
31 Jan 2025
Mighty Kingdom Limited reported a 10% increase in quarterly game revenue to $1.3 million and a 60% improvement in net cash used in operating activities for Q2 FY25, supported by a new $1.2 million secured debt facility while awaiting $2 million in government incentives.
Victor Sage
Victor Sage
31 Jan 2025
Simble Solutions reports a robust Q4 FY24 with a 117% jump in customer receipts and a strategic $280k capital placement, underpinning its growth in energy and sustainability software.
Victor Sage
Victor Sage
31 Jan 2025